InventHelp Inventor Develops Wearable Medical Device (AAT-4114)
PITTSBURGH, Dec. 10, 2018 /PRNewswire/ -- An inventor from Cumming, Ga., has developed the MPAT LIFE BAND, a fully customizable, personal electronic device that can be used to monitor an individual's overall health status.
"The death of a loved one inspired me to develop my idea. When my fiancé died in my arms from a massive heart attack, had she been using an invention like mine, it could have been prevented," said the inventor. "So, at that moment I saw a need for an answer to a problem."
The MPAT LIFE BAND offers a comprehensive patient monitoring system. It helps determine the health and well-being of an individual. This will allow a primary care professional to remotely identify abnormalities, which will allow patients to receive prompt treatment. It offers a stylish yet functional design. This easy-to-set up and use device is producible in various styles and color options.
The original design was submitted to the Atlanta office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 17-AAT-4114, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com.
Sensi.AI, a leader in AI-native, data, and analytics in senior care, today announced the appointment of in-home care leader Bob Roth to its Advisory Board. This partnership is an exciting validation of Sensi.AI's promise to enhance proactive,...
Three major challenges poised to confront the nation's clinical laboratories, genetic test companies, and anatomic pathology laboratories will be major topics when a top-flight roster of lab experts, innovators, and lab leaders gather in New Orleans...
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday,...
Merck , known as MSD outside the United States and Canada, announced that Health Canada has granted approval of KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with fluoropyrimidine- and platinum-containing-chemotherapy, for the...
Globe Life Inc. will release First Quarter 2024 earnings after the market closes on Monday, April 22, 2024. At that time, a copy of the Company's First Quarter 2024 earnings press release and any other financial and statistical information about...
GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925 (KRAS G12C inhibitor) in a...
